Published by Becker’s Healthcare, April 2026 | Author: Aspirion
The Denial Crisis Isn’t a Documentation Problem
Health systems treating rising denial rates as a documentation issue are misreading the situation. This is the output of a deliberate, structural shift in how payers operate—one that has outpaced what any human workflow can sustainably address.
Initial claim denial rates hit 11.81% in 2024, up 2.4% from the prior year. The trajectory tells an even starker story: in 2022, 30% of providers reported that at least 10% of their claims were denied. By 2025, that figure had climbed to 41%. Financially, providers are collecting $3 less per $100 billed compared to last year, AR days are up more than 5%, and collection rates from insured patients have dropped from 37.6% to 34.5%.
The Scrutiny Didn’t Disappear — It Moved
Prior authorization denials dropped 7.7% in 2024, which looks like progress. But medical necessity denials rose 5% over the same period, and requests for additional information jumped 5.4%. Payers have shifted from front-end authorization controls to back-end payment integrity reviews—deploying AI to ingest entire medical records after care is delivered, apply proprietary rule sets, and issue retroactive denials. The provider, who never had access to those criteria before treatment began, now carries the entire burden of rebuttal.
Your Business Office Was Built for a Different Problem
Administrative denials—wrong modifiers, missing information, coding mismatches—are manageable. Clinical denials are not. Disputing medical necessity or a DRG assignment requires digging through hundreds of pages of records, cross-referencing clinical findings against guidelines and contract terms, and building a defensible appeal. When denials arrive in the hundreds or thousands, you simply can’t staff your way out of it.
What AI Changes
AI purpose-built for clinical denials changes the economics. It can surface clinical evidence across thousands of pages, match findings against payer policies, and generate structured appeal drafts for clinical staff to refine. Aspirion’s AI platform has delivered first appeals 2.2x faster, a 20%-plus lift in overturn rates, and cash 20 days sooner—without adding headcount.
Only 14% of providers are currently using AI for denials management. For health systems absorbing compounding denial volume, longer AR cycles, and a payer ecosystem that has already automated its side of the equation, the question is no longer whether AI belongs in the workflow—it’s how quickly the gap can close.
Read the full article here.